NPORT-EX 2 BLK_Strat_Inc_Opps.htm 03.31 BLK STRAT INC OPPS PART F
Consolidated
Schedule
of
Investments
(unaudited)
March
31,
2024
BlackRock
Strategic
Income
Opportunities
Portfolio
1
(Percentages
shown
are
based
on
Net
Assets)
Security
Par
(000)
Pa
r
(
000)
Value
Asset-Backed
Securities
Bermuda
0.1%
(a)(b)
AREIT
LLC,
Series
2023-CRE8,
Class
A,
(1-mo.
CME
Term
SOFR
at
2.21%
Floor
+
2.11%),
7.44%,
08/17/41
.
USD
5,640
$
5,599,042
BPCRE
Ltd.,
Series
2022-FL2,
Class
A,
(1-mo.
CME
Term
SOFR
at
2.40%
Floor
+
2.40%),
7.73%,
01/16/37
.
6,476
6,463,416
OHA
Credit
Funding
11
Ltd.,
Series
2022-11A,
Class
E,
(3-mo.
CME
Term
SOFR
at
7.25%
Floor
+
7.25%),
12.56%,
07/19/33
......
250
252,971
OHA
Credit
Funding
13
Ltd.,
Series
2022-13A,
Class
E,
(3-mo.
CME
Term
SOFR
at
8.55%
Floor
+
8.55%),
13.87%,
07/20/35
......
7,675
7,834,250
Symphony
CLO
38
Ltd.,
Series
2023-
38A,
Class
C1,
(3-mo.
CME
Term
SOFR
at
2.90%
Floor
+
2.90%),
8.22%,
04/24/36
............
2,500
2,525,004
Symphony
CLO
39
Ltd.,
Series
2023-
39A,
Class
E,
(3-mo.
CME
Term
SOFR
at
6.19%
Floor
+
6.19%),
11.60%,
04/25/34
...........
5,000
4,993,856
Symphony
CLO
40
Ltd.,
Series
2023-
40A,
Class
D,
(3-mo.
CME
Term
SOFR
at
5.00%
Floor
+
5.00%),
10.34%,
01/14/34
...........
3,350
3,395,241
TSTAT
Ltd.,
Series
2022-1A,
Class
D1R,
(3-mo.
CME
Term
SOFR
at
4.75%
Floor
+
4.75%),
10.07%,
07/20/31
.................
5,000
4,999,817
36,063,597
Canada
0.1%
Fairstone
Financial
Issuance
Trust
I
(a)
Series
2020-1A,
Class
A,
2.51%,
10/20/39
...............
CAD
8,997
6,498,001
Series
2020-1A,
Class
B,
3.74%,
10/20/39
...............
18,261
12,794,900
Series
2020-1A,
Class
C,
5.16%,
10/20/39
...............
2,125
1,456,195
Series
2020-1A,
Class
D,
6.87%,
10/20/39
...............
150
104,680
20,853,776
Cayman
Islands
6.1%
522
Funding
CLO
Ltd.
(a)(b)
Series
2019-4A,
Class
CR,
(3-mo.
CME
Term
SOFR
at
2.40%
Floor
+
2.66%),
7.98%,
04/20/30
...
USD
500
500,080
Series
2019-4A,
Class
DR,
(3-mo.
CME
Term
SOFR
at
3.65%
Floor
+
3.91%),
9.23%,
04/20/30
...
3,500
3,450,344
ABPCI
DIRECT
LENDING
FUND
CLO
V
Ltd.,
Series
2019-5A,
Class
A1RR,
(3-mo.
CME
Term
SOFR
at
2.20%
Floor
+
2.20%),
7.53%,
01/20/36
(a)
(b)
6,250
6,274,487
ACAS
CLO
Ltd.
(a)(b)
Series
2015-1A,
Class
AR3,
(3-mo.
CME
Term
SOFR
at
0.89%
Floor
+
1.15%),
6.45%,
10/18/28
...
2,008
2,010,221
Series
2015-1A,
Class
BRR,
(3-mo.
CME
Term
SOFR
+
1.86%),
7.16%,
10/18/28
..........
500
498,705
Security
Par
(000)
Par
(000)
Value
Cayman
Islands
(continued)
Series
2015-1A,
Class
CRR,
(3-mo.
CME
Term
SOFR
+
2.46%),
7.76%,
10/18/28
..........
USD
3,690
$
3,688,141
AGL
CLO
3
Ltd.,
Series
2020-3A,
Class
D,
(3-mo.
CME
Term
SOFR
at
3.30%
Floor
+
3.56%),
8.88%,
01/15/33
(a)
(b)
375
372,886
AGL
CLO
5
Ltd.,
Series
2020-5A,
Class
A2R,
(3-mo.
CME
Term
SOFR
at
1.40%
Floor
+
1.66%),
6.98%,
07/20/34
(a)
(b)
...............
390
389,304
AGL
CLO
9
Ltd.,
Series
2020-9A,
Class
E,
(3-mo.
CME
Term
SOFR
at
7.26%
Floor
+
7.52%),
12.84%,
01/20/34
(a)
(b)
...............
1,220
1,211,685
AIMCO
CLO,
Series
2015-AA,
Class
X,
(3-mo.
CME
Term
SOFR
at
0.95%
Floor
+
1.21%),
6.53%,
10/17/34
(a)
(b)
1,458
1,458,595
AIMCO
CLO
12
Ltd.,
Series
2020-12A,
Class
DR,
(3-mo.
CME
Term
SOFR
at
2.90%
Floor
+
2.90%),
8.22%,
01/17/32
(a)
(b)
...............
610
606,677
AIMCO
CLO
14
Ltd.,
Series
2021-14A,
Class
SUB,
0.00%,
04/20/34
(a)
(b)
..
20,000
15,254,000
Allegro
CLO
II-S
Ltd.
(a)(b)
Series
2014-1RA,
Class
B,
(3-mo.
CME
Term
SOFR
at
2.15%
Floor
+
2.41%),
7.73%,
10/21/28
...
2,740
2,740,302
Series
2014-1RA,
Class
C,
(3-mo.
CME
Term
SOFR
at
3.00%
Floor
+
3.26%),
8.58%,
10/21/28
...
7,480
7,466,581
Allegro
CLO
V
Ltd.,
Series
2017-1A,
Class
AR,
(3-mo.
CME
Term
SOFR
at
0.95%
Floor
+
1.21%),
6.53%,
10/16/30
(a)
(b)
...............
7,583
7,580,336
Allegro
CLO
VI
Ltd.,
Series
2017-2A,
Class
A,
(3-mo.
CME
Term
SOFR
at
1.13%
Floor
+
1.39%),
6.71%,
01/17/31
(a)
(b)
...............
987
987,095
Allegro
CLO
VIII
Ltd.
(a)(b)
Series
2018-2A,
Class
A,
(3-mo.
CME
Term
SOFR
at
1.10%
Floor
+
1.36%),
6.68%,
07/15/31
...
8,518
8,525,469
Series
2018-2A,
Class
B1,
(3-mo.
CME
Term
SOFR
at
1.67%
Floor
+
1.93%),
7.25%,
07/15/31
...
500
500,042
Allegro
CLO
XI
Ltd.,
Series
2019-2A,
Class
C,
(3-mo.
CME
Term
SOFR
at
3.00%
Floor
+
3.26%),
8.57%,
01/19/33
(a)
(b)
...............
560
561,352
ALM
Ltd.
(a)(b)
Series
2020-1A,
Class
A2,
(3-mo.
CME
Term
SOFR
+
2.11%),
7.43%,
10/15/29
..........
12,790
12,823,239
Series
2020-1A,
Class
B,
(3-mo.
CME
Term
SOFR
+
2.26%),
7.58%,
10/15/29
..........
500
500,675
ALM
VII
Ltd.,
Series
2012-7A,
Class
SUB,
0.00%,
10/15/2116
(a)
(b)
(c)
...
12,160
1
AMMC
CLO
21
Ltd.,
Series
2017-21A,
Class
A,
(3-mo.
CME
Term
SOFR
at
1.25%
Floor
+
1.51%),
6.83%,
11/02/30
(a)
(b)
...............
1,058
1,058,731
Anchorage
Capital
CLO
3-R
Ltd.
(a)(b)
Series
2014-3RA,
Class
A,
(3-mo.
CME
Term
SOFR
at
1.05%
Floor
+
1.31%),
6.63%,
01/28/31
...
3,148
3,146,398
Consolidated
Schedule
of
Investments
(unaudited)
(continued)
March
31,
2024
BlackRock
Strategic
Income
Opportunities
Portfolio
2
(Percentages
shown
are
based
on
Net
Assets)
Security
Par
(000)
Par
(000)
Value
Cayman
Islands
(continued)
Series
2014-3RA,
Class
B,
(3-mo.
CME
Term
SOFR
at
1.50%
Floor
+
1.76%),
7.08%,
01/28/31
...
USD
9,800
$
9,789,334
Anchorage
Capital
CLO
4-R
Ltd.,
Series
2014-4RA,
Class
C,
(3-mo.
CME
Term
SOFR
at
1.85%
Floor
+
2.11%),
7.43%,
01/28/31
(a)
(b)
....
1,500
1,498,128
Anchorage
Capital
CLO
6
Ltd.,
Series
2015-6A,
Class
ARR,
(3-mo.
CME
Term
SOFR
at
1.05%
Floor
+
1.31%),
6.63%,
07/15/30
(a)
(b)
....
3,087
3,084,292
Anchorage
Capital
CLO
7
Ltd.
(a)(b)
Series
2015-7A,
Class
AR2,
(3-mo.
CME
Term
SOFR
at
1.09%
Floor
+
1.35%),
6.67%,
01/28/31
...
12,223
12,139,369
Series
2015-7A,
Class
BR2,
(3-mo.
CME
Term
SOFR
at
1.75%
Floor
+
2.01%),
7.33%,
01/28/31
...
8,000
8,023,929
Series
2015-7A,
Class
D1R2,
(3-mo.
CME
Term
SOFR
at
3.50%
Floor
+
3.76%),
9.08%,
01/28/31
...
8,860
8,842,007
Anchorage
Capital
CLO
Ltd.
(a)(b)
Series
2013-1A,
Class
A1R,
(3-mo.
CME
Term
SOFR
+
1.51%),
6.83%,
10/13/30
..........
1,459
1,455,474
Series
2013-1A,
Class
A2R,
(3-mo.
CME
Term
SOFR
+
1.91%),
7.23%,
10/13/30
..........
3,680
3,683,334
Series
2013-1A,
Class
BR,
(3-mo.
CME
Term
SOFR
+
2.41%),
7.73%,
10/13/30
..........
1,160
1,161,200
Series
2013-1A,
Class
CR,
(3-mo.
CME
Term
SOFR
+
3.46%),
8.78%,
10/13/30
..........
1,583
1,582,894
Series
2018-1RA,
Class
A1,
(3-mo.
CME
Term
SOFR
at
1.25%
Floor
+
1.25%),
6.57%,
04/13/31
...
5,447
5,434,200
Anchorage
Credit
Funding
14
Ltd.,
Series
2021-14A,
Class
A,
3.00%,
01/21/40
(a)
................
20,250
19,402,801
Anchorage
Credit
Funding
3
Ltd.
(a)
Series
2016-3A,
Class
A1R,
2.87%,
01/28/39
...............
22,000
19,876,312
Series
2016-3A,
Class
A2R,
(3-mo.
CME
Term
SOFR
at
2.10%
Floor
+
2.36%),
7.68%,
01/28/39
(b)
..
4,045
4,024,660
Series
2016-3A,
Class
SUBR,
0.00%,
01/28/39
(b)
.........
7,500
4,675,500
Anchorage
Credit
Funding
Ltd.,
Series
2021-14A,
Class
SUB,
0.00%,
01/21/40
(a)
(b)
...............
10,000
6,987,000
Antares
CLO
Ltd.
(a)(b)
Series
2017-1A,
Class
AR,
(3-mo.
CME
Term
SOFR
at
1.59%
Floor
+
1.85%),
7.17%,
04/20/33
...
3,250
3,249,836
Series
2019-2A,
Class
A1R,
(3-mo.
CME
Term
SOFR
at
1.95%
Floor
+
1.95%),
7.26%,
01/23/36
...
8,470
8,464,955
Series
2021-1A,
Class
A1,
(3-mo.
CME
Term
SOFR
at
1.53%
Floor
+
1.79%),
7.12%,
07/25/33
...
3,250
3,237,879
Security
Par
(000)
Par
(000)
Value
Cayman
Islands
(continued)
Apidos
CLO
XII,
Series
2013-12A,
Class
AR,
(3-mo.
CME
Term
SOFR
at
1.08%
Floor
+
1.34%),
6.66%,
04/15/31
(a)
(b)
...............
USD
20,612
$
20,627,070
Apidos
CLO
XV,
Series
2013-15A,
Class
A1RR,
(3-mo.
CME
Term
SOFR
at
1.01%
Floor
+
1.27%),
6.59%,
04/20/31
(a)
(b)
..........
5,774
5,783,648
Apidos
CLO
XVIII,
Series
2018-18A,
Class
AR,
(3-mo.
CME
Term
SOFR
at
1.15%
Floor
+
1.15%),
6.47%,
10/22/30
(a)
(b)
...............
27,894
28,105,485
Apidos
CLO
XX,
Series
2015-20A,
Class
A1RA,
(3-mo.
CME
Term
SOFR
at
1.10%
Floor
+
1.36%),
6.68%,
07/16/31
(a)
(b)
..........
1,810
1,811,317
Apidos
CLO
XXII
(a)(b)
Series
2015-22A,
Class
A1R,
(3-mo.
CME
Term
SOFR
at
1.06%
Floor
+
1.32%),
6.64%,
04/20/31
...
1,591
1,592,449
Series
2015-22A,
Class
BR,
(3-mo.
CME
Term
SOFR
at
1.95%
Floor
+
2.21%),
7.53%,
04/20/31
...
3,250
3,251,006
Series
2015-22A,
Class
CR,
(3-mo.
CME
Term
SOFR
at
2.95%
Floor
+
3.21%),
8.53%,
04/20/31
...
800
802,562
Apidos
CLO
XXIV,
Series
2016-24A,
Class
A1AL,
(3-mo.
CME
Term
SOFR
at
0.95%
Floor
+
1.21%),
6.53%,
10/20/30
(a)
(b)
..........
21,287
21,297,613
Apidos
CLO
Xxv,
Series
2016-25A,
Class
AJR2,
(3-mo.
CME
Term
SOFR
at
1.50%
Floor
+
1.50%),
6.81%,
10/20/31
(a)
(b)
..........
5,000
4,987,500
Apidos
CLO
XXV,
Series
2016-25A,
Class
A1R2,
(3-mo.
CME
Term
SOFR
at
1.15%
Floor
+
1.15%),
6.46%,
10/20/31
(a)
(b)
..........
11,805
11,775,488
Apidos
CLO
XXVI
(a)(b)
Series
2017-26A,
Class
A1AR,
(3-
mo.
CME
Term
SOFR
at
0.90%
Floor
+
1.16%),
6.46%,
07/18/29
2,115
2,115,629
Series
2017-26A,
Class
BR,
(3-mo.
CME
Term
SOFR
at
1.95%
Floor
+
2.21%),
7.51%,
07/18/29
...
2,750
2,752,417
Apidos
CLO
XXVII,
Series
2017-27A,
Class
A1R,
(3-mo.
CME
Term
SOFR
at
0.93%
Floor
+
1.19%),
6.51%,
07/17/30
(a)
(b)
...............
7,515
7,508,900
Apidos
CLO
XXVIII,
Series
2017-28A,
Class
D,
(3-mo.
CME
Term
SOFR
at
5.50%
Floor
+
5.76%),
11.08%,
01/20/31
(a)
(b)
...............
270
270,427
Apidos
CLO
XXXI,
Series
2019-31A,
Class
BR,
(3-mo.
CME
Term
SOFR
at
1.55%
Floor
+
1.81%),
7.13%,
04/15/31
(a)
(b)
...............
250
250,256
Apidos
CLO
XXXII,
Series
2019-32A,
Class
D,
(3-mo.
CME
Term
SOFR
at
3.50%
Floor
+
3.76%),
9.08%,
01/20/33
(a)
(b)
...............
300
300,037
Apidos
CLO
XXXVI,
Series
2021-36A,
Class
B,
(3-mo.
CME
Term
SOFR
at
1.60%
Floor
+
1.86%),
7.18%,
07/20/34
(a)
(b)
...............
1,320
1,321,074
Consolidated
Schedule
of
Investments
(unaudited)
(continued)
March
31,
2024
BlackRock
Strategic
Income
Opportunities
Portfolio
3
(Percentages
shown
are
based
on
Net
Assets)
Security
Par
(000)
Par
(000)
Value
Cayman
Islands
(continued)
Apidos
CLO
XXXVII,
Series
2021-37A,
Class
E,
(3-mo.
CME
Term
SOFR
at
6.30%
Floor
+
6.56%),
11.88%,
10/22/34
(a)
(b)
...............
USD
850
$
857,826
Arbor
Realty
Commercial
Real
Estate
Notes
Ltd.,
Series
2022-FL2,
Class
A,
(1-mo.
CME
Term
SOFR
at
1.90%
Floor
+
1.85%),
7.18%,
05/15/37
(a)
(b)
19,738
19,688,756
Ares
LI
CLO
Ltd.,
Series
2019-51A,
Class
ER,
(3-mo.
CME
Term
SOFR
at
6.85%
Floor
+
7.11%),
12.43%,
07/15/34
(a)
(b)
...............
300
299,572
Ares
LII
CLO
Ltd.,
Series
2019-52A,
Class
A1R,
(3-mo.
CME
Term
SOFR
at
1.05%
Floor
+
1.31%),
6.63%,
04/22/31
(a)
(b)
...............
2,000
2,001,365
Ares
Loan
Funding
I
Ltd.
(a)(b)
Series
2021-ALFA,
Class
E,
(3-mo.
CME
Term
SOFR
at
6.70%
Floor
+
6.96%),
12.28%,
10/15/34
..
10,850
10,963,884
Series
2021-ALFA,
Class
SUB,
0.00%,
10/15/34
..........
14,000
9,731,400
Ares
Loan
Funding
III
Ltd.,
Series
2022-ALF3A,
Class
E,
(3-mo.
CME
Term
SOFR
at
7.58%
Floor
+
7.58%),
12.90%,
07/25/35
(a)
(b)
...
800
800,532
Ares
LV
CLO
Ltd.,
Series
2020-55A,
Class
DR,
(3-mo.
CME
Term
SOFR
at
3.15%
Floor
+
3.41%),
8.73%,
07/15/34
(a)
(b)
...............
750
753,978
Ares
XL
CLO
Ltd.,
Series
2016-40A,
Class
A1RR,
(3-mo.
CME
Term
SOFR
at
0.87%
Floor
+
1.13%),
6.45%,
01/15/29
(a)
(b)
..........
3,009
3,007,648
Ares
XLV
CLO
Ltd.,
Series
2017-45A,
Class
C,
(3-mo.
CME
Term
SOFR
at
2.05%
Floor
+
2.31%),
7.63%,
10/15/30
(a)
(b)
...............
1,125
1,126,412
Ares
XLVII
CLO
Ltd.,
Series
2018-47A,
Class
A1,
(3-mo.
CME
Term
SOFR
at
0.92%
Floor
+
1.18%),
6.50%,
04/15/30
(a)
(b)
...............
1,860
1,853,682
Ares
XXXVII
CLO
Ltd.,
Series
2015-4A,
Class
A1R,
(3-mo.
CME
Term
SOFR
at
1.17%
Floor
+
1.43%),
6.75%,
10/15/30
(a)
(b)
...............
1,151
1,152,069
Assurant
CLO
Ltd.,
Series
2018-2A,
Class
A,
(3-mo.
CME
Term
SOFR
at
1.04%
Floor
+
1.30%),
6.62%,
04/20/31
(a)
(b)
...............
1,044
1,045,094
Atrium
IX
(a)(b)
Series
9A,
Class
AR2,
(3-mo.
CME
Term
SOFR
at
0.99%
Floor
+
1.25%),
6.59%,
05/28/30
....
2,253
2,253,640
Series
9A,
Class
BR2,
(3-mo.
CME
Term
SOFR
at
1.50%
Floor
+
1.76%),
7.10%,
05/28/30
....
325
325,549
Atrium
VIII,
Series
8A,
Class
SUB,
0.00%,
10/23/24
(a)
(b)
..........
13,300
5,054
Atrium
XV,
Series
15A,
Class
D,
(3-mo.
CME
Term
SOFR
at
3.00%
Floor
+
3.26%),
8.58%,
01/23/31
(a)
(b)
....
1,450
1,448,255
Bain
Capital
Credit
CLO
Ltd.
(a)(b)
Series
2017-1A,
Class
A1R,
(3-mo.
CME
Term
SOFR
at
0.97%
Floor
+
1.23%),
6.55%,
07/20/30
...
719
719,445
Security
Par
(000)
Par
(000)
Value
Cayman
Islands
(continued)
Series
2017-1A,
Class
BR,
(3-mo.
CME
Term
SOFR
at
1.50%
Floor
+
1.76%),
7.08%,
07/20/30
...
USD
1,400
$
1,398,479
Series
2018-1A,
Class
A1,
(3-mo.
CME
Term
SOFR
at
0.26%
Floor
+
1.22%),
6.54%,
04/23/31
...
11,242
11,238,908
Series
2018-2A,
Class
A1,
(3-mo.
CME
Term
SOFR
at
1.08%
Floor
+
1.34%),
6.65%,
07/19/31
...
4,795
4,784,624
Ballyrock
CLO
14
Ltd.
(a)(b)
Series
2020-14A,
Class
B,
(3-mo.
CME
Term
SOFR
at
2.56%
Floor
+
2.56%),
7.88%,
01/20/34
...
250
251,026
Series
2020-14A,
Class
D,
(3-mo.
CME
Term
SOFR
at
7.26%
Floor
+
7.26%),
12.58%,
01/20/34
..
250
251,273
Ballyrock
CLO
25
Ltd.,
Series
2023-
25A,
Class
C,
(3-mo.
CME
Term
SOFR
at
4.70%
Floor
+
4.70%),
10.02%,
01/25/36
(a)
(b)
.........
1,750
1,770,656
Ballyrock
CLO
Ltd.
(a)(b)
Series
2018-1A,
Class
A1,
(3-mo.
CME
Term
SOFR
+
1.26%),
6.58%,
04/20/31
..........
569
569,050
Series
2018-1A,
Class
A2,
(3-mo.
CME
Term
SOFR
+
1.86%),
7.18%,
04/20/31
..........
2,300
2,307,037
Series
2020-2A,
Class
DR,
(3-mo.
CME
Term
SOFR
at
6.15%
Floor
+
6.41%),
11.73%,
10/20/31
..
1,340
1,347,688
Bardot
CLO
Ltd.,
Series
2019-2A,
Class
DR,
(3-mo.
CME
Term
SOFR
at
3.00%
Floor
+
3.26%),
8.58%,
10/22/32
(a)
(b)
...............
940
938,793
Barings
CLO
Ltd.
(a)(b)
Series
2015-IA,
Class
AR,
(3-mo.
CME
Term
SOFR
at
0.99%
Floor
+
1.25%),
6.57%,
01/20/31
...
2,917
2,918,268
Series
2015-IA,
Class
BR,
(3-mo.
CME
Term
SOFR
at
1.40%
Floor
+
1.66%),
6.98%,
01/20/31
...
250
249,920
Series
2018-3A,
Class
A1,
(3-mo.
CME
Term
SOFR
at
0.95%
Floor
+
1.21%),
6.53%,
07/20/29
...
1,327
1,326,496
Battalion
CLO
IX
Ltd.,
Series
2015-9A,
Class
DR,
(3-mo.
CME
Term
SOFR
at
3.25%
Floor
+
3.51%),
8.83%,
07/15/31
(a)
(b)
...............
450
444,195
Battalion
CLO
VIII
Ltd.,
Series
2015-8A,
Class
A2R2,
(3-mo.
CME
Term
SOFR
at
1.55%
Floor
+
1.81%),
7.11%,
07/18/30
(a)
(b)
..........
11,000
11,000,120
Bean
Creek
CLO
Ltd.,
Series
2015-1A,
Class
AR,
(3-mo.
CME
Term
SOFR
at
1.28%
Floor
+
1.28%),
6.60%,
04/20/31
(a)
(b)
...............
1,560
1,559,469
Benefit
Street
Partners
CLO
V-B
Ltd.,
Series
2018-5BA,
Class
A1A,
(3-mo.
CME
Term
SOFR
at
1.09%
Floor
+
1.35%),
6.67%,
04/20/31
(a)
(b)
....
3,442
3,444,745
Benefit
Street
Partners
CLO
VIII
Ltd.,
Series
2015-8A,
Class
A1AR,
(3-mo.
CME
Term
SOFR
at
1.10%
Floor
+
1.36%),
6.68%,
01/20/31
(a)
(b)
....
2,837
2,839,084
Consolidated
Schedule
of
Investments
(unaudited)
(continued)
March
31,
2024
BlackRock
Strategic
Income
Opportunities
Portfolio
4
(Percentages
shown
are
based
on
Net
Assets)
Security
Par
(000)
Par
(000)
Value
Cayman
Islands
(continued)
Benefit
Street
Partners
CLO
XII
Ltd.,
Series
2017-12A,
Class
B,
(3-mo.
CME
Term
SOFR
+
2.26%),
7.58%,
10/15/30
(a)
(b)
...............
USD
1,375
$
1,376,104
Benefit
Street
Partners
CLO
XX
Ltd.,
Series
2020-20A,
Class
ER,
(3-mo.
CME
Term
SOFR
at
6.75%
Floor
+
7.01%),
12.33%,
07/15/34
(a)
(b)
...
1,000
1,002,521
Benefit
Street
Partners
CLO
XXIII
Ltd.,
Series
2021-23A,
Class
E,
(3-mo.
CME
Term
SOFR
at
6.81%
Floor
+
7.07%),
12.40%,
04/25/34
(a)
(b)
...
1,250
1,249,801
Betony
CLO
2
Ltd.,
Series
2018-1A,
Class
A1,
(3-mo.
CME
Term
SOFR
at
1.08%
Floor
+
1.34%),
6.66%,
04/30/31
(a)
(b)
...............
17,190
17,198,282
Birch
Grove
CLO
2
Ltd.,
Series
2021-
2A,
Class
D1,
(3-mo.
CME
Term
SOFR
at
3.30%
Floor
+
3.56%),
8.87%,
10/19/34
(a)
(b)
..........
5,250
5,209,163
Birch
Grove
CLO
Ltd.
(a)(b)
Series
19A,
Class
BR,
(3-mo.
CME
Term
SOFR
at
1.75%
Floor
+
2.01%),
7.34%,
06/15/31
....
2,000
2,002,345
Series
19A,
Class
DR,
(3-mo.
CME
Term
SOFR
at
3.35%
Floor
+
3.61%),
8.94%,
06/15/31
....
4,795
4,786,022
BlueMountain
CLO
Ltd.
(a)(b)
Series
2013-2A,
Class
A1R,
(3-mo.
CME
Term
SOFR
at
1.18%
Floor
+
1.44%),
6.76%,
10/22/30
...
2,655
2,657,112
Series
2013-2A,
Class
BR,
(3-mo.
CME
Term
SOFR
at
1.60%
Floor
+
1.86%),
7.18%,
10/22/30
...
4,000
4,003,958
Series
2015-3A,
Class
A1R,
(3-mo.
CME
Term
SOFR
at
1.00%
Floor
+
1.26%),
6.58%,
04/20/31
...
215
215,648
Series
2016-2A,
Class
C1R2,
(3-mo.
CME
Term
SOFR
at
3.10%
Floor
+
3.36%),
8.68%,
08/20/32
...
250
243,693
Series
2016-3A,
Class
A1R2,
(3-mo.
CME
Term
SOFR
at
1.20%
Floor
+
1.20%),
6.51%,
11/15/30
...
2,000
2,000,000
Series
2016-3A,
Class
A2R2,
(3-mo.
CME
Term
SOFR
at
1.70%
Floor
+
1.70%),
7.01%,
11/15/30
...
7,400
7,400,000
Series
2018-1A,
Class
B,
(3-mo.
CME
Term
SOFR
at
1.70%
Floor
+
1.96%),
7.28%,
07/30/30
...
273
272,846
Series
2018-2A,
Class
A,
(3-mo.
CME
Term
SOFR
at
0.11%
Floor
+
1.37%),
6.68%,
08/15/31
...
1,137
1,140,860
Series
2018-2A,
Class
B,
(3-mo.
CME
Term
SOFR
at
1.70%
Floor
+
1.96%),
7.27%,
08/15/31
...
2,750
2,752,054
Series
2018-3A,
Class
A1R,
(3-mo.
CME
Term
SOFR
at
1.19%
Floor
+
1.19%),
6.51%,
10/25/30
...
14,950
14,949,904
Series
2018-3A,
Class
A2R,
(3-mo.
CME
Term
SOFR
at
1.60%
Floor
+
1.60%),
6.92%,
10/25/30
...
9,000
8,999,960
BlueMountain
CLO
XXII
Ltd.,
Series
2018-22A,
Class
A1,
(3-mo.
CME
Term
SOFR
at
1.08%
Floor
+
1.34%),
6.66%,
07/15/31
(a)
(b)
....
1,410
1,410,770
Security
Par
(000)
Par
(000)
Value
Cayman
Islands
(continued)
BlueMountain
CLO
XXIX
Ltd.,
Series
2020-29A,
Class
D1R,
(3-mo.
CME
Term
SOFR
at
3.15%
Floor
+
3.41%),
8.74%,
07/25/34
(a)
(b)
....
USD
250
$
245,533
BlueMountain
CLO
XXVIII
Ltd.
(a)(b)
Series
2021-28A,
Class
A,
(3-mo.
CME
Term
SOFR
at
1.26%
Floor
+
1.52%),
6.84%,
04/15/34
...
450
450,191
Series
2021-28A,
Class
D,
(3-mo.
CME
Term
SOFR
at
2.90%
Floor
+
3.16%),
8.48%,
04/15/34
...
2,000
1,953,270
BlueMountain
CLO
XXX
Ltd.,
Series
2020-30A,
Class
ER,
(3-mo.
CME
Term
SOFR
at
6.70%
Floor
+
6.70%),
12.01%,
04/15/35
(a)
(b)
...
250
231,679
BlueMountain
CLO
XXXIII
Ltd.,
Series
2021-33A,
Class
D,
(3-mo.
CME
Term
SOFR
at
3.50%
Floor
+
3.76%),
9.08%,
11/20/34
(a)
(b)
....
1,510
1,463,056
BlueMountain
Fuji
US
CLO
I
Ltd.,
Series
2017-1A,
Class
A1R,
(3-mo.
CME
Term
SOFR
at
0.98%
Floor
+
1.24%),
6.56%,
07/20/29
(a)
(b)
....
23,950
23,949,738
BlueMountain
Fuji
US
CLO
II
Ltd.,
Series
2017-2A,
Class
A1AR,
(3-mo.
CME
Term
SOFR
+
1.26%),
6.58%,
10/20/30
(a)
(b)
...............
3,599
3,600,850
Bristol
Park
CLO
Ltd.
(a)(b)
Series
2016-1A,
Class
BR,
(3-mo.
CME
Term
SOFR
at
1.45%
Floor
+
1.71%),
7.03%,
04/15/29
...
6,250
6,258,100
Series
2016-1A,
Class
DR,
(3-mo.
CME
Term
SOFR
at
2.95%
Floor
+
3.21%),
8.53%,
04/15/29
...
500
496,814
Buttermilk
Park
CLO
Ltd.,
Series
2018-1A,
Class
D,
(3-mo.
CME
Term
SOFR
at
3.10%
Floor
+
3.36%),
8.68%,
10/15/31
(a)
(b)
..........
875
863,015
Canyon
CLO
Ltd.,
Series
2020-3A,
Class
E,
(3-mo.
CME
Term
SOFR
at
7.25%
Floor
+
7.51%),
12.83%,
01/15/34
(a)
(b)
...............
1,430
1,412,199
Carbone
CLO
Ltd.,
Series
2017-1A,
Class
A1,
(3-mo.
CME
Term
SOFR
at
1.14%
Floor
+
1.40%),
6.72%,
01/20/31
(a)
(b)
...............
3,238
3,238,309
Carlyle
Global
Market
Strategies
CLO
Ltd.
(a)(b)
Series
2013-4A,
Class
A1RR,
(3-mo.
CME
Term
SOFR
at
1.00%
Floor
+
1.26%),
6.58%,
01/15/31
...
1,361
1,355,338
Series
2014-1A,
Class
A1R2,
(3-mo.
CME
Term
SOFR
at
0.97%
Floor
+
1.23%),
6.55%,
04/17/31
...
20,404
20,405,785
Series
2014-2RA,
Class
A1,
(3-mo.
CME
Term
SOFR
at
1.05%
Floor
+
1.31%),
6.62%,
05/15/31
...
3,260
3,262,707
Series
2014-3RA,
Class
A1A,
(3-mo.
CME
Term
SOFR
+
1.31%),
6.63%,
07/27/31
..........
31,337
31,341,000
Series
2015-1A,
Class
AR3,
(3-mo.
CME
Term
SOFR
at
0.98%
Floor
+
1.24%),
6.56%,
07/20/31
...
440
440,499
Series
2015-4A,
Class
A1R,
(3-mo.
CME
Term
SOFR
+
1.60%),
6.92%,
07/20/32
..........
400
400,060
Consolidated
Schedule
of
Investments
(unaudited)
(continued)
March
31,
2024
BlackRock
Strategic
Income
Opportunities
Portfolio
5
(Percentages
shown
are
based
on
Net
Assets)
Security
Par
(000)
Par
(000)
Value
Cayman
Islands
(continued)
Carlyle
US
CLO
Ltd.
(a)(b)
Series
2017-2A,
Class
A1R,
(3-mo.
CME
Term
SOFR
at
1.05%
Floor
+
1.31%),
6.63%,
07/20/31
...
USD
4,636
$
4,642,868
Series
2017-3A,
Class
A1AR,
(3-mo.
CME
Term
SOFR
at
0.90%
Floor
+
1.16%),
6.48%,
07/20/29
...
1,867
1,868,686
Series
2017-4A,
Class
A1,
(3-mo.
CME
Term
SOFR
at
1.18%
Floor
+
1.44%),
6.76%,
01/15/30
...
1,831
1,832,314
Series
2018-4A,
Class
A2,
(3-mo.
CME
Term
SOFR
at
1.80%
Floor
+
2.06%),
7.38%,
01/20/31
...
550
549,175
Series
2019-1A,
Class
A1AR,
(3-mo.
CME
Term
SOFR
at
1.08%
Floor
+
1.34%),
6.66%,
04/20/31
...
1,000
1,000,500
CarVal
CLO
I
Ltd.,
Series
2018-1A,
Class
D,
(3-mo.
CME
Term
SOFR
+
3.15%),
8.47%,
07/16/31
(a)
(b)
....
1,705
1,693,431
CarVal
CLO
II
Ltd.
(a)(b)
Series
2019-1A,
Class
CR,
(3-mo.
CME
Term
SOFR
at
2.26%
Floor
+
2.26%),
7.58%,
04/20/32
...
700
700,584
Series
2019-1A,
Class
DR,
(3-mo.
CME
Term
SOFR
at
3.46%
Floor
+
3.46%),
8.78%,
04/20/32
...
2,000
1,991,484
CarVal
CLO
III
Ltd.,
Series
2019-2A,
Class
E,
(3-mo.
CME
Term
SOFR
at
6.70%
Floor
+
6.70%),
12.02%,
07/20/32
(a)
(b)
...............
1,300
1,284,976
CarVal
CLO
VC
Ltd.
(a)(b)
Series
2021-2A,
Class
D,
(3-mo.
CME
Term
SOFR
at
3.25%
Floor
+
3.51%),
8.83%,
10/15/34
...
500
497,871
Series
2021-2A,
Class
E,
(3-mo.
CME
Term
SOFR
at
6.75%
Floor
+
7.01%),
12.33%,
10/15/34
..
250
248,027
Cathedral
Lake
CLO
Ltd.,
Series
2013-
1A,
Class
A1R3,
(3-mo.
CME
Term
SOFR
at
1.02%
Floor
+
1.28%),
6.60%,
10/15/29
(a)
(b)
..........
6,966
6,965,764
CBAM
Ltd.
(a)(b)
Series
2017-1A,
Class
A1,
(3-mo.
CME
Term
SOFR
+
1.51%),
6.83%,
07/20/30
..........
12,801
12,824,430
Series
2017-1A,
Class
C,
(3-mo.
CME
Term
SOFR
+
2.66%),
7.98%,
07/20/30
..........
750
750,478
Series
2018-7A,
Class
B1,
(3-mo.
CME
Term
SOFR
at
1.60%
Floor
+
1.86%),
7.18%,
07/20/31
...
1,000
999,000
Series
2019-9A,
Class
B2,
(3-mo.
CME
Term
SOFR
at
1.90%
Floor
+
2.16%),
7.48%,
02/12/30
...
4,750
4,712,281
Cedar
Funding
IX
CLO
Ltd.
(a)(b)
Series
2018-9A,
Class
A1,
(3-mo.
CME
Term
SOFR
at
0.98%
Floor
+
1.24%),
6.56%,
04/20/31
...
25,651
25,666,718
Series
2018-9A,
Class
D,
(3-mo.
CME
Term
SOFR
at
2.60%
Floor
+
2.86%),
8.18%,
04/20/31
...
250
249,185
Cedar
Funding
V
CLO
Ltd.,
Series
2016-5A,
Class
A1R,
(3-mo.
CME
Term
SOFR
at
1.10%
Floor
+
1.36%),
6.68%,
07/17/31
(a)
(b)
....
5,036
5,039,043
Security
Par
(000)
Par
(000)
Value
Cayman
Islands
(continued)
Cedar
Funding
VII
CLO
Ltd.
(a)(b)
Series
2018-7A,
Class
A1,
(3-mo.
CME
Term
SOFR
at
1.00%
Floor
+
1.26%),
6.58%,
01/20/31
...
USD
2,990
$
2,990,531
Series
2018-7A,
Class
A2,
(3-mo.
CME
Term
SOFR
at
1.13%
Floor
+
1.39%),
6.71%,
01/20/31
...
250
250,405
Series
2018-7A,
Class
E,
(3-mo.
CME
Term
SOFR
at
4.55%
Floor
+
4.81%),
10.13%,
01/20/31
..
2,963
2,784,724
Series
2018-7A,
Class
SUB,
0.00%,
01/20/31
...............
1,750
450,659
Cedar
Funding
XI
CLO
Ltd.,
Series
2019-11A,
Class
A2R,
(3-mo.
CME
Term
SOFR
at
1.35%
Floor
+
1.61%),
6.95%,
05/29/32
(a)
(b)
....
1,000
998,661
Cedar
Funding
XIV
CLO
Ltd.
(a)(b)
Series
2021-14A,
Class
B,
(3-mo.
CME
Term
SOFR
at
1.60%
Floor
+
1.86%),
7.18%,
07/15/33
...
4,000
3,981,718
Series
2021-14A,
Class
D,
(3-mo.
CME
Term
SOFR
at
3.25%
Floor
+
3.51%),
8.83%,
07/15/33
...
13,750
13,174,267
Series
2021-14A,
Class
E,
(3-mo.
CME
Term
SOFR
at
6.34%
Floor
+
6.60%),
11.92%,
07/15/33
..
4,975
4,868,944
Series
2021-14A,
Class
SUB,
0.00%,
07/15/33
..........
15,290
7,272,997
CIFC
Funding
2013-IV
Ltd.,
Series
2013-4A,
Class
A1RR,
(3-mo.
CME
Term
SOFR
at
1.06%
Floor
+
1.32%),
6.64%,
04/27/31
(a)
(b)
....
4,850
4,853,327
CIFC
Funding
2018-III
Ltd.,
Series
2018-3A,
Class
A,
(3-mo.
CME
Term
SOFR
+
1.36%),
6.66%,
07/18/31
(a)
(b)
7,563
7,564,291
CIFC
Funding
2019-III
Ltd.,
Series
2019-3A,
Class
DR,
(3-mo.
CME
Term
SOFR
at
6.80%
Floor
+
7.06%),
12.38%,
10/16/34
(a)
(b)
...
2,275
2,280,560
CIFC
Funding
2022-VII
Ltd.,
Series
2022-7A,
Class
E,
(3-mo.
CME
Term
SOFR
at
8.94%
Floor
+
8.94%),
14.26%,
10/22/35
(a)
(b)
.........
1,200
1,225,909
CIFC
Funding
Ltd.
(a)(b)
Series
2013-1A,
Class
A2R,
(3-mo.
CME
Term
SOFR
at
1.75%
Floor
+
2.01%),
7.33%,
07/16/30
...
1,250
1,253,125
Series
2013-1A,
Class
CR,
(3-mo.
CME
Term
SOFR
at
3.55%
Floor
+
3.81%),
9.13%,
07/16/30
...
500
500,152
Series
2013-2A,
Class
A1L2,
(3-mo.
CME
Term
SOFR
at
1.00%
Floor
+
1.26%),
6.56%,
10/18/30
...
20,048
20,047,965
Series
2013-3RA,
Class
A1,
(3-mo.
CME
Term
SOFR
at
0.98%
Floor
+
1.24%),
6.56%,
04/24/31
...
11,224
11,237,751
Series
2013-3RA,
Class
B,
(3-mo.
CME
Term
SOFR
at
1.85%
Floor
+
2.11%),
7.43%,
04/24/31
...
650
647,606
Series
2013-3RA,
Class
C,
(3-mo.
CME
Term
SOFR
at
2.90%
Floor
+
3.16%),
8.48%,
04/24/31
...
1,050
1,042,159
Series
2013-4A,
Class
DRR,
(3-mo.
CME
Term
SOFR
at
2.80%
Floor
+
3.06%),
8.38%,
04/27/31
...
250
248,432
Consolidated
Schedule
of
Investments
(unaudited)
(continued)
March
31,
2024
BlackRock
Strategic
Income
Opportunities
Portfolio
6
(Percentages
shown
are
based
on
Net
Assets)
Security
Par
(000)
Par
(000)
Value
Cayman
Islands
(continued)
Series
2014-1A,
Class
A1R2,
(3-mo.
CME
Term
SOFR
+
1.36%),
6.66%,
01/18/31
..........
USD
540
$
539,661
Series
2014-2RA,
Class
A1,
(3-mo.
CME
Term
SOFR
at
1.05%
Floor
+
1.31%),
6.63%,
04/24/30
...
8,662
8,663,501
Series
2014-2RA,
Class
B1,
(3-mo.
CME
Term
SOFR
at
2.80%
Floor
+
3.06%),
8.38%,
04/24/30
...
650
650,248
Series
2014-3A,
Class
A1R2,
(3-mo.
CME
Term
SOFR
+
1.46%),
6.78%,
10/22/31
..........
827
827,797
Series
2014-5A,
Class
A1R2,
(3-mo.
CME
Term
SOFR
at
1.20%
Floor
+
1.46%),
6.78%,
10/17/31
...
1,000
1,000,282
Series
2015-1A,
Class
ARR,
(3-mo.
CME
Term
SOFR
at
1.11%
Floor
+
1.37%),
6.69%,
01/22/31
...
31,276
31,285,517
Series
2015-1A,
Class
BRR,
(3-mo.
CME
Term
SOFR
at
1.45%
Floor
+
1.71%),
7.03%,
01/22/31
...
400
399,385
Series
2015-3A,
Class
AR,
(3-mo.
CME
Term
SOFR
at
0.87%
Floor
+
1.13%),
6.44%,
04/19/29
...
4,307
4,308,352
Series
2015-3A,
Class
BR,
(3-mo.
CME
Term
SOFR
at
1.15%
Floor
+
1.41%),
6.72%,
04/19/29
...
8,750
8,736,179
Series
2017-2A,
Class
AR,
(3-mo.
CME
Term
SOFR
at
0.95%
Floor
+
1.21%),
6.53%,
04/20/30
...
8,275
8,280,244
Series
2017-3A,
Class
A1,
(3-mo.
CME
Term
SOFR
at
1.22%
Floor
+
1.48%),
6.80%,
07/20/30
...
8,471
8,474,374
Series
2017-4A,
Class
A1R,
(3-mo.
CME
Term
SOFR
at
0.95%
Floor
+
1.21%),
6.53%,
10/24/30
...
15,044
15,056,051
Series
2017-5A,
Class
A1,
(3-mo.
CME
Term
SOFR
+
1.44%),
6.76%,
11/16/30
..........
14,853
14,868,238
Series
2017-5A,
Class
C,
(3-mo.
CME
Term
SOFR
+
3.11%),
8.43%,
11/16/30
..........
800
797,226
Series
2018-1A,
Class
A,
(3-mo.
CME
Term
SOFR
+
1.26%),
6.56%,
04/18/31
..........
230
229,825
Series
2018-2A,
Class
A1,
(3-mo.
CME
Term
SOFR
+
1.30%),
6.62%,
04/20/31
..........
6,646
6,654,242
Series
2018-4A,
Class
A1,
(3-mo.
CME
Term
SOFR
at
1.15%
Floor
+
1.41%),
6.73%,
10/17/31
...
22,798
22,813,852
Series
2021-4A,
Class
B,
(3-mo.
CME
Term
SOFR
at
1.58%
Floor
+
1.84%),
7.16%,
07/15/33
...
500
499,827
Clear
Creek
CLO
Ltd.
(a)(b)
Series
2015-1A,
Class
AR,
(3-mo.
CME
Term
SOFR
at
1.20%
Floor
+
1.46%),
6.78%,
10/20/30
...
1,232
1,233,364
Series
2015-1A,
Class
DR,
(3-mo.
CME
Term
SOFR
at
2.95%
Floor
+
3.21%),
8.53%,
10/20/30
...
2,900
2,894,210
Crown
City
CLO
III,
Series
2021-1A,
Class
A1A,
(3-mo.
CME
Term
SOFR
at
1.17%
Floor
+
1.43%),
6.75%,
07/20/34
(a)
(b)
...............
250
249,157
Security
Par
(000)
Par
(000)
Value
Cayman
Islands
(continued)
Crown
Point
CLO
9
Ltd.,
Series
2020-
9A,
Class
DR,
(3-mo.
CME
Term
SOFR
at
3.75%
Floor
+
4.01%),
9.33%,
07/14/34
(a)
(b)
..........
USD
1,000
$
982,698
Deer
Creek
CLO
Ltd.
(a)(b)
Series
2017-1A,
Class
A,
(3-mo.
CME
Term
SOFR
+
1.44%),
6.76%,
10/20/30
..........
1,670
1,672,707
Series
2017-1A,
Class
B,
(3-mo.
CME
Term
SOFR
+
1.91%),
7.23%,
10/20/30
..........
1,750
1,733,503
Series
2017-1A,
Class
D,
(3-mo.
CME
Term
SOFR
at
2.95%
Floor
+
3.21%),
8.53%,
10/20/30
...
900
898,381
Series
2017-1A,
Class
E,
(3-mo.
CME
Term
SOFR
at
6.35%
Floor
+
6.61%),
11.93%,
10/20/30
..
1,500
1,503,358
Diameter
Capital
CLO
2
Ltd.,
Series
2021-2A,
Class
D,
(3-mo.
CME
Term
SOFR
at
6.32%
Floor
+
6.32%),
11.64%,
10/15/36
(a)
(b)
.........
1,500
1,479,586
Dryden
106
CLO
Ltd.,
Series
2022-
106A,
Class
E,
(3-mo.
CME
Term
SOFR
at
8.87%
Floor
+
8.87%),
14.18%,
10/15/35
(a)
(b)
.........
500
508,285
Dryden
30
Senior
Loan
Fund,
Series
2013-30A,
Class
AR,
(3-mo.
CME
Term
SOFR
at
0.82%
Floor
+
1.08%),
6.39%,
11/15/28
(a)
(b)
....
12,111
12,076,660
Dryden
36
Senior
Loan
Fund,
Series
2014-36A,
Class
AR3,
(3-mo.
CME
Term
SOFR
at
1.02%
Floor
+
1.28%),
6.60%,
04/15/29
(a)
(b)
....
7,972
7,974,550
Dryden
37
Senior
Loan
Fund,
Series
2015-37A,
Class
AR,
(3-mo.
CME
Term
SOFR
at
1.10%
Floor
+
1.36%),
6.68%,
01/15/31
(a)
(b)
....
1,370
1,370,166
Dryden
41
Senior
Loan
Fund,
Series
2015-41A,
Class
AR,
(3-mo.
CME
Term
SOFR
at
0.97%
Floor
+
1.23%),
6.55%,
04/15/31
(a)
(b)
....
4,309
4,301,994
Dryden
45
Senior
Loan
Fund,
Series
2016-45A,
Class
CR,
(3-mo.
CME
Term
SOFR
at
2.20%
Floor
+
2.46%),
7.78%,
10/15/30
(a)
(b)
....
375
373,935
Dryden
49
Senior
Loan
Fund
(a)(b)
Series
2017-49A,
Class
AR,
(3-mo.
CME
Term
SOFR
at
0.95%
Floor
+
1.21%),
6.51%,
07/18/30
...
653
652,868
Series
2017-49A,
Class
BR,
(3-mo.
CME
Term
SOFR
at
1.60%
Floor
+
1.86%),
7.16%,
07/18/30
...
1,000
1,001,123
Dryden
50
Senior
Loan
Fund,
Series
2017-50A,
Class
B,
(3-mo.
CME
Term
SOFR
at
1.65%
Floor
+
1.91%),
7.23%,
07/15/30
(a)
(b)
....
250
249,655
Dryden
55
CLO
Ltd.,
Series
2018-55A,
Class
A1,
(3-mo.
CME
Term
SOFR
+
1.28%),
6.60%,
04/15/31
(a)
(b)
....
679
679,452
Dryden
58
CLO
Ltd.,
Series
2018-58A,
Class
A1,
(3-mo.
CME
Term
SOFR
+
1.26%),
6.58%,
07/17/31
(a)
(b)
....
3,742
3,741,623
Dryden
65
CLO
Ltd.,
Series
2018-65A,
Class
B,
(3-mo.
CME
Term
SOFR
at
1.60%
Floor
+
1.86%),
7.16%,
07/18/30
(a)
(b)
...............
700
701,763
Consolidated
Schedule
of
Investments
(unaudited)
(continued)
March
31,
2024
BlackRock
Strategic
Income
Opportunities
Portfolio
7
(Percentages
shown
are
based
on
Net
Assets)
Security
Par
(000)
Par
(000)
Value
Cayman
Islands
(continued)
Dryden
77
CLO
Ltd.,
Series
2020-77A,
Class
XR,
(3-mo.
CME
Term
SOFR
at
1.00%
Floor
+
1.26%),
6.58%,
05/20/34
(a)
(b)
...............
USD
141
$
140,540
Dryden
78
CLO
Ltd.,
Series
2020-78A,
Class
D,
(3-mo.
CME
Term
SOFR
at
3.00%
Floor
+
3.26%),
8.58%,
04/17/33
(a)
(b)
...............
250
247,834
Dryden
Senior
Loan
Fund,
Series
2017-
47A,
Class
A1R,
(3-mo.
CME
Term
SOFR
at
0.98%
Floor
+
1.24%),
6.56%,
04/15/28
(a)
(b)
..........
2,839
2,839,462
Dryden
XXVI
Senior
Loan
Fund,
Series
2013-26A,
Class
AR,
(3-mo.
CME
Term
SOFR
at
0.90%
Floor
+
1.16%),
6.48%,
04/15/29
(a)
(b)
....
2,457
2,457,921
Dryden
XXVIII
Senior
Loan
Fund,
Series
2013-28A,
Class
A1LR,
(3-mo.
CME
Term
SOFR
at
1.20%
Floor
+
1.46%),
6.77%,
08/15/30
(a)
(b)
20,338
20,337,563
Elevation
CLO
Ltd.,
Series
2014-2A,
Class
A1R,
(3-mo.
CME
Term
SOFR
+
1.49%),
6.81%,
10/15/29
(a)
(b)
...
44
43,672
Elmwood
CLO
14
Ltd.,
Series
2022-1A,
Class
E,
(3-mo.
CME
Term
SOFR
at
6.35%
Floor
+
6.35%),
11.67%,
04/20/35
(a)
(b)
...............
4,900
4,897,147
Elmwood
CLO
22
Ltd.,
Series
2023-1A,
Class
E,
(3-mo.
CME
Term
SOFR
at
7.65%
Floor
+
7.65%),
12.97%,
04/17/36
(a)
(b)
...............
2,000
2,001,222
Elmwood
CLO
II
Ltd.
(a)(b)
Series
2019-2A,
Class
DR,
(3-mo.
CME
Term
SOFR
at
3.00%
Floor
+
3.26%),
8.58%,
04/20/34
...
750
747,199
Series
2019-2A,
Class
ER,
(3-mo.
CME
Term
SOFR
at
6.80%
Floor
+
7.06%),
12.38%,
04/20/34
..
14,750
14,777,397
Series
2019-2A,
Class
FR,
(3-mo.
CME
Term
SOFR
at
8.00%
Floor
+
8.26%),
13.58%,
04/20/34
..
7,500
7,056,041
Series
2019-2A,
Class
SUB,
0.00%,
04/20/34
...............
4,000
3,178,000
Elmwood
CLO
III
Ltd.,
Series
2019-3A,
Class
ER,
(3-mo.
CME
Term
SOFR
at
6.50%
Floor
+
6.76%),
12.08%,
10/20/34
(a)
(b)
...............
500
503,734
Elmwood
CLO
IV
Ltd.,
Series
2020-1A,
Class
E,
(3-mo.
CME
Term
SOFR
at
6.60%
Floor
+
6.86%),
12.18%,
04/15/33
(a)
(b)
...............
4,300
4,340,540
Elmwood
CLO
V
Ltd.,
Series
2020-2A,
Class
ER,
(3-mo.
CME
Term
SOFR
at
6.10%
Floor
+
6.36%),
11.68%,
10/20/34
(a)
(b)
...............
5,350
5,401,890
Elmwood
CLO
X
Ltd.
(a)(b)
Series
2021-3A,
Class
A,
(3-mo.
CME
Term
SOFR
at
1.04%
Floor
+
1.30%),
6.62%,
10/20/34
...
1,000
1,000,800
Series
2021-3A,
Class
E,
(3-mo.
CME
Term
SOFR
at
5.85%
Floor
+
6.11%),
11.43%,
10/20/34
..
3,000
2,985,095
Flatiron
CLO
18
Ltd.,
Series
2018-1A,
Class
A,
(3-mo.
CME
Term
SOFR
at
0.95%
Floor
+
1.21%),
6.53%,
04/17/31
(a)
(b)
...............
1,150
1,150,824
Security
Par
(000)
Par
(000)
Value
Cayman
Islands
(continued)
Flatiron
CLO
19
Ltd.,
Series
2019-1A,
Class
DR,
(3-mo.
CME
Term
SOFR
at
3.00%
Floor
+
3.26%),
8.59%,
11/16/34
(a)
(b)
...............
USD
800
$
799,870
FS
Rialto,
Series
2021-FL3,
Class
A,
(1-mo.
CME
Term
SOFR
at
1.36%
Floor
+
1.36%),
6.69%,
11/16/36
(a)
(b)
2,184
2,172,890
Galaxy
31
CLO
Ltd.,
Series
2023-31A,
Class
E,
(3-mo.
CME
Term
SOFR
at
8.43%
Floor
+
8.43%),
13.74%,
04/15/36
(a)
(b)
...............
650
660,853
Galaxy
XIX
CLO
Ltd.,
Series
2015-19A,
Class
A1RR,
(3-mo.
CME
Term
SOFR
at
0.95%
Floor
+
1.21%),
6.53%,
07/24/30
(a)
(b)
..........
2,156
2,156,698
Galaxy
XV
CLO
Ltd.,
Series
2013-15A,
Class
ARR,
(3-mo.
CME
Term
SOFR
at
0.97%
Floor
+
1.23%),
6.55%,
10/15/30
(a)
(b)
...............
3,907
3,907,094
Galaxy
XVIII
CLO
Ltd.,
Series
2018-
28A,
Class
A1,
(3-mo.
CME
Term
SOFR
at
1.10%
Floor
+
1.36%),
6.68%,
07/15/31
(a)
(b)
..........
2,484
2,486,087
Galaxy
XXII
CLO
Ltd.,
Series
2016-
22A,
Class
ARR,
(3-mo.
CME
Term
SOFR
at
1.20%
Floor
+
1.46%),
6.78%,
04/16/34
(a)
(b)
..........
850
852,281
Galaxy
XXVI
CLO
Ltd.,
Series
2018-
26A,
Class
A,
(3-mo.
CME
Term
SOFR
at
1.46%
Floor
+
1.46%),
6.79%,
11/22/31
(a)
(b)
..........
855
855,176
Galaxy
XXVII
CLO
Ltd.,
Series
2018-
27A,
Class
A,
(3-mo.
CME
Term
SOFR
at
1.02%
Floor
+
1.28%),
6.61%,
05/16/31
(a)
(b)
..........
16,390
16,393,622
Galaxy
XXVIII
CLO
Ltd.,
Series
2018-
28A,
Class
A2,
(3-mo.
CME
Term
SOFR
at
1.07%
Floor
+
1.56%),
6.88%,
07/15/31
(a)
(b)
..........
488
489,409
Generate
CLO
2
Ltd.,
Series
2A,
Class
AR,
(3-mo.
CME
Term
SOFR
at
1.15%
Floor
+
1.41%),
6.73%,
01/22/31
(a)
(b)
...............
15,788
15,791,980
Generate
CLO
4
Ltd.
(a)(b)
Series
2016-2A,
Class
ER,
(3-mo.
CME
Term
SOFR
at
6.75%
Floor
+
7.01%),
12.33%,
04/20/32
..
250
249,836
Series
4A,
Class
A1R,
(3-mo.
CME
Term
SOFR
at
1.09%
Floor
+
1.35%),
6.67%,
04/20/32
....
930
929,681
Series
4A,
Class
BR,
(3-mo.
CME
Term
SOFR
at
1.55%
Floor
+
1.81%),
7.13%,
04/20/32
....
2,750
2,752,825
Series
4A,
Class
DR,
(3-mo.
CME
Term
SOFR
at
3.15%
Floor
+
3.41%),
8.73%,
04/20/32
....
1,500
1,496,930
Generate
CLO
5
Ltd.,
Series
5A,
Class
B,
(3-mo.
CME
Term
SOFR
at
1.75%
Floor
+
2.01%),
7.33%,
10/22/31
(a)
(b)
1,750
1,756,678
Generate
CLO
8
Ltd.,
Series
8A,
Class
ER,
(3-mo.
CME
Term
SOFR
at
6.95%
Floor
+
7.21%),
12.53%,
10/20/34
(a)
(b)
...............
4,250
4,271,902
Consolidated
Schedule
of
Investments
(unaudited)
(continued)
March
31,
2024
BlackRock
Strategic
Income
Opportunities
Portfolio
8
(Percentages
shown
are
based
on
Net
Assets)
Security
Par
(000)
Par
(000)
Value
Cayman
Islands
(continued)
Gilbert
Park
CLO
Ltd.
(a)(b)
Series
2017-1A,
Class
A,
(3-mo.
CME
Term
SOFR
at
1.19%
Floor
+
1.45%),
6.77%,
10/15/30
...
USD
2,583
$
2,584,611
Series
2017-1A,
Class
C,
(3-mo.
CME
Term
SOFR
at
1.95%
Floor
+
2.21%),
7.53%,
10/15/30
...
7,160
7,168,866
Series
2017-1A,
Class
D,
(3-mo.
CME
Term
SOFR
at
2.95%
Floor
+
3.21%),
8.53%,
10/15/30
...
11,473
11,475,617
GoldenTree
Loan
Management
US
CLO
3
Ltd.,
Series
2018-3A,
Class
D,
(3-mo.
CME
Term
SOFR
+
3.11%),
8.43%,
04/20/30
(a)
(b)
....
750
750,642
GoldenTree
Loan
Management
US
CLO
5
Ltd.,
Series
2019-5A,
Class
BR,
(3-mo.
CME
Term
SOFR
at
1.55%
Floor
+
1.81%),
7.13%,
10/20/32
(a)
(b)
...............
2,040
2,041,499
GoldenTree
Loan
Opportunities
XI
Ltd.,
Series
2015-11A,
Class
AR2,
(3-mo.
CME
Term
SOFR
at
1.07%
Floor
+
1.33%),
6.63%,
01/18/31
(a)
(b)
....
3,244
3,247,425
GoldentTree
Loan
Management
US
CLO
1
Ltd.,
Series
2021-11A,
Class
E,
(3-mo.
CME
Term
SOFR
at
5.35%
Floor
+
5.61%),
10.93%,
10/20/34
(a)
(b)
...............
5,765
5,567,364
Golub
Capital
Partners
CLO
37B
Ltd.,
Series
2018-37A,
Class
E,
(3-mo.
CME
Term
SOFR
at
5.75%
Floor
+
6.01%),
11.33%,
07/20/30
(a)
(b)
....
7,500
7,480,973
Golub
Capital
Partners
CLO
46M
Ltd.,
Series
2019-46A,
Class
B,
(3-mo.
CME
Term
SOFR
at
2.65%
Floor
+
2.91%),
8.23%,
04/20/32
(a)
(b)
....
2,000
2,020,328
Golub
Capital
Partners
CLO
55B
Ltd.,
Series